Browse Lab Results > 2011-0028
Trial Summary
About CDAS Project, PI, Publications: Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Datasets
Site: Lymphoid
Inclusion Criteria:
- No Rare Cancers
- Tested for MGUS in Previous Study
- Serum Available
- Serum Available from Same Study Year as MGUS Sample
Matching Factors:
- Gender
- Race (W/B/O)
- Study Year of Draw
- Age at Draw
- Date of Draw
Match Ratio: 3:1
Match Technique: Individual matching only non-cases as controls.
Additional Matching Comments: Draw age +/- 2 years and draw date +/- 90 days were considered optimal. These were progressively loosened to attain matches. 8 case sets are incomplete due to age/date of draw proximity being inadequate.
Analytes:
- Adiponectin
- High-Molecular Weight Adiponectin
Number of Cases: 79
Number of Controls: 229
Site: Lymphoid
Inclusion Criteria:
- No Prior History of Any Cancer
- No Rare Cancers in Controls
- Heparin Plasma Available
- Pre-DX Heparin Plasma Available
- Cases: Incident Cancers Only
Matching Factors:
- Gender
- Race (5 levels, combined minorities)
- Time of Blood Draw (am/pm)
- Entry Season and Year
- Age at Randomization (5 year intervals)
- Study Year of Blood Draw
Match Ratio: 2-to-1
Match Technique: Individual matching with replacement and cases as controls.
Additional Matching Comments: The cases and controls were split into tree categories: 2009-00506 cases/controls, 'clean' cases/controls (1st cancers), and 'dirty' cases/controls (1st MM/Lymphoma dx). The controls were then rematched to GWAS subjects (without replacement).
Analytes:
- Adiponectin
- High-Molecular Weight Adiponectin
- Leptin
Number of Cases: 174
Number of Controls: 348